drugset / Trial / NCT00331604
Safety and Efficacy of Inhaled Insulin in Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Asia, Europe and South America. The aim of this research is to compare the efficacy (reduction in HbA1c and blood glucose) and pulmonary safety (pulmonary function tests, chest x-rays) of mealtime inhaled insulin with subcutaneous insulin aspart both in combination with insulin detemir in Type 2 Diabetes.
Timeline
- Start
- 2006-08-31
- Primary completion
- 2008-05-05
- Completion
- 2008-05-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Other |
| Comparator | insulin aspart | Protein / enzyme biologic | — | Subcutaneous |
| Background | insulin detemir | Protein / enzyme biologic | — | Subcutaneous |